Literature DB >> 2966920

An N-terminal region of adenovirus E1a essential for cell transformation and induction of an epithelial cell growth factor.

T Subramanian1, M Kuppuswamy, R J Nasr, G Chinnadurai.   

Abstract

A new region of the adenovirus E1a protein essential for immortalization and transformation of primary rat kidney cells has been identified. This region is located between amino acid residues 18 to 20 in an N-terminal domain that is not conserved among the various adenovirus serotypes. The transformation defective mutant (18-0) mapping in this region is not impaired in its ability to trans-activate the viral E2 promoter and to repress the activity of certain enhancer elements. Mutant 18-0 appears to have only a partial defect in the induction of cellular DNA synthesis in quiescent primary cells suggesting that the N-terminal region plays a role in immortalization and transformation by a mechanism that may not fully depend on induction of cellular DNA synthesis. Mutant 18-0 and another transformation defective mutant (125-7) mapping between amino acid residues 125 to 127 in a conserved domain are defective in the induction of an epithelial cell growth factor, suggesting that growth factor induction may be important for some aspect of adenovirus mediated immortalization and transformation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2966920

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Repression of c-Myc and inhibition of G1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity.

Authors:  Sudhakar Baluchamy; Hasan N Rajabi; Rama Thimmapaya; Arunasalam Navaraj; Bayar Thimmapaya
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

2.  Promoter-specific trans-activation by the adenovirus E1A12S product involves separate E1A domains.

Authors:  V B Kraus; E Moran; J R Nevins
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

3.  Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein.

Authors:  J S Mymryk; R W Lee; S T Bayley
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

4.  Adenovirus E1A makes two distinct contacts with the retinoblastoma protein.

Authors:  N Dyson; P Guida; C McCall; E Harlow
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

5.  Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification.

Authors:  P Yaciuk; E Moran
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

6.  Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins.

Authors:  E White; R Cipriani; P Sabbatini; A Denton
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

7.  Maintenance of cellular proliferation by adenovirus early region 1A in fibroblasts conditionally immortalized by using simian virus 40 large T antigen requires conserved region 1.

Authors:  T E Riley; A Follin; N C Jones; P S Jat
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

8.  p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen.

Authors:  N L Lill; M J Tevethia; R Eckner; D M Livingston; N Modjtahedi
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  Transgenic expression in mouse lung reveals distinct biological roles for the adenovirus type 5 E1A 243- and 289-amino-acid proteins.

Authors:  Yongping Yang; Colin McKerlie; Steven H Borenstein; Zhan Lu; Marco Schito; John W Chamberlain; Manuel Buchwald
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Simian virus 40 large-T antigen expresses a biological activity complementary to the p300-associated transforming function of the adenovirus E1A gene products.

Authors:  P Yaciuk; M C Carter; J M Pipas; E Moran
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.